Nov 20 - By Associated Press
Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults.
Nov 20 - By Associated Press
Drug developer Pfizer Inc. said Friday the Food and Drug Administration approved an intravenous version of its high blood pressure drug Revatio.
Nov 20 - By Associated Press
Health care company Covidien PLC said Friday the Food and Drug Administration will take longer than expected to review the potential opioid pain drug Exalgo.
Nov 20 - By Associated Press
Biotechnology company Dendreon Corp. said Friday the Food and Drug Administration will make a regulatory decision on the potential prostate cancer vaccine Provenge by May 1.
Nov 19 - By Associated Press
The Food and Drug Administration said Thursday it issued 22 warning letters to Web site operators over alleged illegal sales of unapproved or misbranded drugs.
Nov 18 - By Associated Press
Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration is withholding a decision to expand approval of Rituxan as a leukemia treatment, pending further discussion.

Nov 18 - By Marley Seaman, AP Health Writer
Medtronic said Wednesday it is responding to a warning letter from the Food and Drug Administration about procedures at the Minnesota headquarters of its heart implants division.
Nov 17 - By Associated Press
Shares of biotechnology company NeurogesX Inc. jumped Tuesday after the company received Food and Drug Administration approval for its Qutenza pain patch.
Nov 16 - By Associated Press
Human Genome Sciences Inc. said Monday the Food and Drug Administration will not approve the company's anthrax treatment until it receives additional information on the potential drug.
Nov 16 - By Associated Press
Genzyme Corp. said Monday the Food and Drug Administration will not approve the potential Pompe disease treatment Lumizyme until the company fixes manufacturing problems at the company's Boston-area facility.
Nov 13 - By Matthew Perrone, AP Business Writer
The Food and Drug Administration is challenging makers of alcohol-infused energy drinks to prove their beverages are safe, citing complaints that the products can cause risky behavior and injury.
Nov 11 - By Associated Press
In a Nov. 9 story and headline about a Food and Drug Administration review of a drug being developed by XenoPort Inc. and GlaxoSmithKline PLC, The Associated Press reported erroneously on the nature of the FDA review. The FDA is considering an application for the drug in restless legs syndrome, not neuropathic pain.
Nov 10 - By Associated Press
Teva Pharmaceutical Industries Ltd. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid.
Nov 9 - By Associated Press
The Food and Drug Administration needs three more months to review an application to a neuropathic pain drug being developed by XenoPort Inc. and GlaxoSmithKline PLC, the companies said.
Nov 6 - By Michael Felberbaum, AP Tobacco Writer
The Food and Drug Administration said Friday that it has warned several companies to stop selling banned flavored cigarettes to U.S. consumers online.
Nov 4 - By Matthew Perrone, AP Business Writer
The Food and Drug Administration is launching a program to try and prevent millions of accidental drug overdoses that occur each year due to medication errors, misuse and other problems.
Oct 30 - By Associated Press
The U.S. Food and Drug Administration sent a warning letter Friday to Procter & Gamble Co. saying the company was illegally marketing two Vicks cold and flu medicines containing vitamin C.
Oct 29 - By Associated Press
Gen-Probe Inc. said Thursday the Food and Drug Administration granted emergency approval to its diagnostic test for the 2009 swine flu.
Oct 26 - By Associated Press
Unilever PLC said late Monday it has decided to phase out use of the Smart Choices logo on its food and beverage products now that the Food and Drug Administration plans to standardize criteria for food nutrition labels.

Oct 25 - By Matthew Perrone, AP Business Writer
The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients' lives, say congressional investigators.
Oct 25 - By Associated Press
Shire PLC said the U.S. Food and Drug Administration reaffirmed a prior decision to give the attention-deficit-hyperactivity disorder drug Vyvanse five years of market exclusivity.
Oct 23 - By Associated Press
The Food and Drug Administration says Human Genome Sciences' ABthrax successfully treated animals exposed to anthrax, though the agency has questions about its use in humans.
Oct 22 - By The Associated Press, Only on msnbc.com
After a federal cigarette tax took effect in April and as the U.S. Food and Drug Administration's authority over the industry increases, tobacco companies are wary of the impact on their products and looking to cigarette alternatives such as smokeless tobacco for future growth.
Oct 19 - By Associated Press
GlaxoSmithKline PLC said Monday the Food and Drug Administration approved the seasonal flu vaccine Fluarix for children.
Oct 18 - By Associated Press
Amgen says the Food and Drug Administration wants more information about its osteoporosis treatment Prolia before granting marketing approval. It delays a drug seen as a potential blockbuster for the company.